compound introduction
MGL-IN-1 是一种高效、选择性的不可逆 MGL (β-内酰胺基单酰甘油脂肪酶)抑制剂。MGL-IN-1 在体内多发性硬化症模型中缓解疾病症状，在体内急性炎性疼痛模型中表现出镇痛作用。MGL-IN-1 具有较高的膜通透性和血脑屏障通透性。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
NF 1819
CAS number：1881244-28-5 molecular formula：C24H22FN5O4
overview
Specs
| Chinese alias | (3R,4S)-rel-4-(1,3-苯并二恶唑-5-基)-3-(4-氟苯基)-1-[1-(1H)-1,2,4-三唑-1-羰基)-4-哌啶基] -2-氮杂环丁酮 | ||
| English alias | (3R,4S)-rel-4-(1,3-Benzodioxol-5-yl)-3-(4-fluorophenyl)-1-[1-(1H)-1,2,4-triazol-1-carbonyl)-4-piperidinyl]-2-azetidinone | NF-1819 | NF1819 | MGL-IN-1 | ||
| CAS number | 1881244-28-5 | molecular formula | C24H22FN5O4 |
| molecular weight | 463.46 g/mol | Exact mass | ≥98%(HPLC) |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
